
Bellevue Entrepreneur Switzerland (CH)
ISIN-No.: CH0379353722
YTD: 1.05%
Active share: 44.88
Anzahl Positionen: 42
Explained in 90 seconds
Owner-operated or family-run companies think in generations, not in quarters
Solid balance sheets, high innovative strength and safety awareness have a positive effect on the share price
Companies impress with high ESG scores
Indexed performance (as at: 10.04.2026)
NAV: CHF 159.60 (09.04.2026)
Rolling performance (10.04.2026)
| B-CHF | Benchmark | |
| 09.04.2025 - 09.04.2026 | 31.26% | 30.14% |
| 09.04.2024 - 09.04.2025 | -10.75% | -7.81% |
| 09.04.2023 - 09.04.2024 | -0.70% | 1.60% |
| 09.04.2022 - 09.04.2023 | -3.54% | -6.54% |
Annualized performance (10.04.2026)
| B-CHF | Benchmark | |
| 1 year | 31.26% | 30.14% |
| 3 years | 5.17% | 6.82% |
| 5 years | 1.96% | 4.50% |
| Since Inception p.a. | 5.68% | 6.75% |
Cumulative performance (10.04.2026)
| B-CHF | Benchmark | |
| 1M | 2.15% | 1.34% |
| YTD | 1.05% | 2.17% |
| 1 year | 31.26% | 30.14% |
| 3 years | 16.32% | 21.89% |
| 5 years | 10.18% | 24.60% |
| Since Inception | 60.95% | 75.44% |
Annual performance
| B-CHF | Benchmark | |
| 2025 | 17.88% | 16.92% |
| 2024 | 1.40% | 3.83% |
| 2023 | 8.23% | 6.53% |
| 2022 | -24.89% | -17.83% |
Facts & Key figures
Investment Focus
The fund actively invests in listed owner-managed companies in Switzerland where an entrepreneur or a founder family holds at least a 20% of a company’s voting rights. The qualities of these companies – a focused business model, Show moreShow less
Investment suitability & Risk
Low risk
High risk
General Information
| Investment Manager | Bellevue Asset Management AG |
| Custodian | CACEIS Bank, Montrouge, Zurich Branch |
| Fund Administrator | CACEIS Bank, Montrouge, Zurich Branch |
| Auditor | PriceWaterhouseCoopers |
| Launch date | 04.04.2006 |
| Year end closing | 31. Dec |
| NAV Calculation | Daily "Forward Pricing" |
| Cut of time | 15:00 CET |
| Management Fee | 1.25% |
| Subscription Fee (max.) | 5.00% |
| ISIN number | CH0379353722 |
| Valor number | 37935372 |
| Bloomberg | PMBESWB SW |
Legal Information
| Legal form | Investment funds under Swiss law |
| SFDR category | Article 8 |
| Redemption period | Daily |
Key data (31.03.2026, base currency CHF)
| Beta | 1.03 |
| Volatility | 12.51 |
| Tracking error | 3.50 |
| Active share | 44.88 |
| Correlation | 0.96 |
| Sharpe ratio | 0.25 |
| Information ratio | -0.52 |
| Jensen's alpha | -2.10 |
| No. of positions | 42 |
Portfolio
Top 10 positions
Market capitalization
Breakdown by sector
Benefits & Risks
Benefits
- Above-average top line growth driven by high innovation and strong pricing power.
- Higher operating margins on the back of high market share ("Champion in the niche") combined with good cost discipline.
- More conservatively financed, lower debt exposure and a higher risk capacity compared to non-family businesses.
- Multi-award-winning management team with a long and successful track record investing in owner-run firms.
- Entrepreneurs for entrepreneurs – the Bellevue Group is itself an owner-run company with the majority of shares held by employees.
Risks
- The fund actively invests in equities. Equities are subject to price fluctuations and so are also exposed to the risk of price losses.
- Shares in smaller businesses are generally traded in lower volumes and are subject to bigger price fluctuations than larger enterprises.
- The fund may invest a proportion of its assets in financial instruments that might under certain circumstances have a relatively low level of liquidity, which can in turn affect the fund’s liquidity.
- Succession planning poses an additional risk for owner-run companies.
- The fund may engage in derivatives transactions. The increased opportunities gained come with an increased risk of losses.
Review / Outlook
Swiss SMID Caps as measured by the SPIEX Index declined (-6.5%) in the month, outperforming the SMI (-7.6%). The drawdown was driven by the escalation of the Iran conflict, including the temporary closure of the Strait of Hormuz, triggering a sharp energy shock with oil prices exceeding USD 100/bbl. Central banks remained on hold during the month but with a clear hawkish bias given the risk of a supply side energy inflation shock. Towards month-end, first signs of de-escalation caused modest pullbacks in energy prices. The Eurozone Composite PMI edged down to 50.5 in March, signaling continued but slower expansion. Overall growth was dragged down by a sharp reduction in the service sector, while manufacturing proved resilient (51.6), with Germany hitting a 45-month high of 51.7. The procure.ch manufacturing PMI jumped to 53.3 from 47.4, well above expectations, signaling a clear return to expansion - the first since December 2022. From a sector perspective Utilities (+3.8%), Financials (-0.6%) and Real Estate (-0.7%) performed best while Industrials (-10.4%), Consumer Discretionary (-9.3%) and Information Technology (-8.4%) lagged the most.
Against this backdrop, the fund (B shares, CHF) declined -5.9%, outperforming the benchmark by 60 bp.
The main detractors during the month were Burckhardt Compression (-17.9%), Montana Aerospace (-17.1%) and Inficon (-16.8%). For Burckhardt Compression we understand the H2 order momentum (year end 31.3) did not improve a lot sequentially and customers have stayed cautious amid uncertainty in the Middle East. Despite short term turbulences, the backdrop is remains favourable to Burckhardt’s narrative of energy security, transition and infrastructure capex spending. Management expressed confidence in achieving the mid-term targets. Montana aerospace corrected massively amidst Airbus revising its production guidance. Despite the war in Iran, Montana reiterated its conservative guidance for 2026 and sees stable supply chains so far. However, 2027 guidance fell short of analysts’ expectations leading to negative EPS revisions. Inficon had pre-released 2025 revenue as well as EBIT. In the wake of the many actual uncertainties management’s 2026 revenue guidance was at the lower end of consensus expectations and the muted margin outlook was a damper despite sound activity and order intake in the semi space. We expect further updates in the coming quarters and remain positive.
The top three contributors were Aryzta (+11.8%), Gurit (+43.5%) and Polypeptide (+10.3%). Aryzta benefited from solid FY 2025 results, slightly above expectations, particularly at the free cash flow (FCF). It guided for low to mid-single digit (L-MSD) organic growth and EBITDA expansion. Gurit released encouraging 2025 results, highlighting improved profitability from a streamlined perimeter following the exit from the carbon fiber business. With guidance pointing to single digit revenue growth and margin expansion, 2026 is set to confirm the improving trends seen in H2. PolyPeptide reported very strong FY 2025 results, driven by a sharp profitability increase following the ramp-up of a key GLP-1 contract. For 2026, it guided for 20-25% revenue growth and mid- to high-teen margins, implying a 400-600bps improvement, which should support strong EPS growth.
The Middle East and Hormuz remain key uncertainties. The magnitude and duration of the conflict and its effect on the global economy remain difficult to assess, and markets are reacting sensitively in both directions. Following a sensitivity analysis of the portfolio, we implemented selective adjustments to balance the portfolio relative to energy prices and interest rate volatility. Overall, the fund performed relatively well and we could close the month with slight outperformance. Interestingly, SMID did not underperform in the draw down, despite higher exposure to industrials. Defensive sectors like healthcare, household & personal care (HPC) and food and beverage (F&B) did not provide shelter and the structural exposure of industrials names to themes like defence, sovereignty, energy transition, electrification etc. makes the segment potentially less cyclical.
Dokumente
Show moreShow less




